{"schema_version":"secwatch.filing_event.v1","accession":"0000875320-24-000142","form_type":"8-K","ticker":"VRTX","cik":"0000875320","company_name":"VERTEX PHARMACEUTICALS INC / MA","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.243458+00:00","generated_at":"2026-06-01T23:56:44.803197+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Vertex Pharmaceuticals Shareholders Elect Directors and Approve Proposals at Annual Meeting","bullets":["Shareholders elected all 11 board nominees, including Reshma Kewalramani and Jeffrey Leiden, with each receiving over 217 million votes for.","Ratification of Ernst & Young as independent auditor for FY2024 approved with 229,460,523 votes for, 3,987,619 against.","Advisory vote on 2023 executive compensation program passed with 202,098,575 votes for, 19,223,784 against.","Shareholder proposal for special shareholder meeting improvement approved with 160,438,357 votes for, 61,494,550 against.","Shareholder proposal on racial and gender pay gaps report did not pass, receiving only 63,865,687 for vs 157,637,997 against."],"urls":{"canonical":"https://secwatch.observer/filing/0000875320-24-000142","json":"https://secwatch.observer/filing/0000875320-24-000142.json","markdown":"https://secwatch.observer/filing/0000875320-24-000142.md","text":"https://secwatch.observer/filing/0000875320-24-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/vrtx-20240515.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T23:56:44.803197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"050cd4312bd14bcb170075c7d34abed20a1abcff","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Reshma Kewalramani as director at the 2024-05-15 meeting.","evidence_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"0612d613e1f02125fa5360d55bc3394c8d49a677","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Bruce Sachs as director at the 2024-05-15 meeting.","evidence_excerpt":",689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"2502c46c9fa0d0b2f8e347834c597f5789c2a93a","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Jeffrey Leiden as director at the 2024-05-15 meeting.","evidence_excerpt":"08,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"5d7446c2353dc232df7037877d773edc3dc4d441","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Alan Garber as director at the 2024-05-15 meeting.","evidence_excerpt":"as members of the Company's Board of Directors until the annual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"67ead2eca542b64b21f581f45096b6d57be2a0ca","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Jennifer Schneider as director at the 2024-05-15 meeting.","evidence_excerpt":"6 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"a4291ac63971e62450f0f2689bb04b5c977695a9","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Lloyd Carney as director at the 2024-05-15 meeting.","evidence_excerpt":"neider, Nancy Thornberry and Suketu Upadhyay to serve as members of the Company's Board of Directors until the annual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"b490952e370652605405cb71039c978cec67a5e0","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Sangeeta Bhatia, Lloyd Carney, Alan Garber, Reshma Kewalramani, Michel Lagarde, Jeffrey Leiden, Diana McKenzie, Bruce Sachs, Jennifer Schneider, Nancy Thornberry and Suketu Upadhyay as directors at the 2024-05-15 meeting.","evidence_excerpt":"Based upon the following votes, the shareholders elected Sangeeta Bhatia, Lloyd Carney, Alan Garber, Reshma Kewalramani, Michel Lagarde, Jeffrey Leiden, Diana McKenzie, Bruce Sachs, Jennifer Schneider, Nancy Thornberry and Suketu Upadhyay to serve as members of the Company's Board of Directors until the annual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"bc5d081ebd8f9196257fac1ea7301f3dee070fed","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for 2024 at the 2024-05-15 meeting.","evidence_excerpt":"Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024: For Against Abstain Non-Votes 229,460,523 3,987,619 290,126 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"c0d220512eb19170aae5f2ecf869ddb4f0371849","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Diana McKenzie as director at the 2024-05-15 meeting.","evidence_excerpt":",558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"c3ffa016e5c689aef23624e7ee8df6dd58da435e","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Michel Lagarde as director at the 2024-05-15 meeting.","evidence_excerpt":"gainst Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"c4824692944f92d45446f743cbb160dd64ee9dbe","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Shareholder proposal regarding a special shareholder meeting improvement at the 2024-05-15 meeting.","evidence_excerpt":"Based upon the following votes, the shareholders approved a shareholder proposal regarding a special shareholder meeting improvement: For Against Abstain Non-Votes 160,438,357 61,494,550 265,212 11,540,149","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"e3b79391fc8c4246ff0dc2d7e75d325219626293","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Advisory approval of 2023 compensation program for named executive officers at the 2024-05-15 meeting.","evidence_excerpt":"Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers: For Against Abstain Non-Votes 202,098,575 19,223,784 875,760 11,540,149","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"ea0271753174c2066e2dcb6af87af952e8188a95","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders rejected Shareholder proposal regarding a report on racial and gender pay gaps at the 2024-05-15 meeting.","evidence_excerpt":"Based upon the following votes, the shareholders did not approve a shareholder proposal regarding a report on racial and gender pay gaps: For Against Abstain Non-Votes 63,865,687 157,637,997 694,435 11,540,149","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"ea9b51a5eeaacbdac9d1e25c0f180e85118266df","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Nancy Thornberry as director at the 2024-05-15 meeting.","evidence_excerpt":"186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9},{"claim_id":"ef98a3a1e9515c64c4c53745fc218662004af303","claim":"VERTEX PHARMACEUTICALS INC / MA shareholders approved Election of Suketu Upadhyay as director at the 2024-05-15 meeting.","evidence_excerpt":"178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No. 2 : Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024: For Against Abstain Non-Votes 229,460,523 3,987,619 290,126 0 Proposal No.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001193125-26-253493","ticker":"NTGR","company_name":"NETGEAR, INC.","filed_at":"2026-06-02T20:08:54+00:00","headline":"NETGEAR stockholders elect six directors, ratify PwC as auditor, approve say-on-pay at 2026 annual meeting","event_type":"other_material","sec_items":["5.07"],"materiality_score":0.3,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253493","json":"https://secwatch.observer/filing/0001193125-26-253493.json","markdown":"https://secwatch.observer/filing/0001193125-26-253493.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1122904/000119312526253493/0001193125-26-253493-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1122904/000119312526253493/d215077d8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"2. Ratification of the appointment of PricewaterhouseCoopers, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For: 22,460,670 Against: 475,197 Abstain: 12,195 Broker Non-Votes: —","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1122904/000119312526253493/0001193125-26-253493-index.htm"}},{"accession":"0001437749-26-019162","ticker":"HPK","company_name":"HighPeak Energy, Inc.","filed_at":"2026-06-02T20:02:25+00:00","headline":"HighPeak Energy stockholders elect three Class C directors and approve say-on-pay at 2026 annual meeting","event_type":"other_material","sec_items":["5.07"],"materiality_score":0.5,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-019162","json":"https://secwatch.observer/filing/0001437749-26-019162.json","markdown":"https://secwatch.observer/filing/0001437749-26-019162.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792849/000143774926019162/0001437749-26-019162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792849/000143774926019162/hpe20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"Votes For Votes Against Votes Abstained Broker Non-Votes 82,986,947 4,884,646 40,091 11,238,238","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1792849/000143774926019162/0001437749-26-019162-index.htm"}},{"accession":"0001079973-26-000763","ticker":"DUOT","company_name":"DUOS TECHNOLOGIES GROUP, INC.","filed_at":"2026-06-02T12:30:17+00:00","headline":"Duos Tech annual meeting: all five director nominees elected, auditor ratified","event_type":"other_material","sec_items":["5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-26-000763","json":"https://secwatch.observer/filing/0001079973-26-000763.json","markdown":"https://secwatch.observer/filing/0001079973-26-000763.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396536/000107997326000763/0001079973-26-000763-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396536/000107997326000763/duot_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"Votes For Votes With held Charles P. Ferry 17,287,342 378,458 Frank A. Lonegro 12,275,595 5,390,205 Ned Mavrommatis 12,492,813 5,172,987 James Craig Nixon 12,863,671 4,802,129 Brian J. James 17,359,835 305,965","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1396536/000107997326000763/0001079973-26-000763-index.htm"}},{"accession":"0001753926-26-000960","ticker":"SRTS","company_name":"Sensus Healthcare, Inc.","filed_at":"2026-06-02T12:26:11+00:00","headline":"Sensus Healthcare shareholders re-elect directors, approve advisory vote on pay, ratify auditor","event_type":"other_material","sec_items":["5.07"],"materiality_score":0.25,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-26-000960","json":"https://secwatch.observer/filing/0001753926-26-000960.json","markdown":"https://secwatch.observer/filing/0001753926-26-000960.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000175392626000960/0001753926-26-000960-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000175392626000960/g085751_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"2. Advisory Vote on Executive Compensation . Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for 2025. The tabulation of votes cast was as follows: For Against Abstention Broker Non-Votes 4,740,572 856,128 722,554 5,000,719","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000175392626000960/0001753926-26-000960-index.htm"}},{"accession":"0001193125-26-251659","ticker":"MPT","company_name":"MEDICAL PROPERTIES TRUST INC","filed_at":"2026-06-01T20:55:09+00:00","headline":"MPT shareholders elect all directors, approve say-on-pay and equity plan with notable opposition","event_type":"other_material","sec_items":["5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251659","json":"https://secwatch.observer/filing/0001193125-26-251659.json","markdown":"https://secwatch.observer/filing/0001193125-26-251659.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287865/000119312526251659/0001193125-26-251659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287865/000119312526251659/mpt-20260528.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"Proposal 3: The approval of a non-binding, advisory vote on named executive officer compensation: For: Against: Abstensions: Broker Non-Votes: 245,721,749 96,721,390 3,853,035 122,390,383","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1287865/000119312526251659/0001193125-26-251659-index.htm"}},{"accession":"0001628280-26-039572","ticker":"VOYG","company_name":"Voyager Technologies, Inc./DE","filed_at":"2026-06-01T20:49:39+00:00","headline":"Stockholders approve redomestication from Delaware to Texas at annual meeting","event_type":"other_material","sec_items":["5.07"],"materiality_score":0.55,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039572","json":"https://secwatch.observer/filing/0001628280-26-039572.json","markdown":"https://secwatch.observer/filing/0001628280-26-039572.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788060/000162828026039572/0001628280-26-039572-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788060/000162828026039572/voyg-20260529.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788060/000162828026039572/0001628280-26-039572-index.htm"}},{"accession":"0001579684-26-000040","ticker":"TDAY","company_name":"USA TODAY Co., Inc.","filed_at":"2026-06-01T20:31:33+00:00","headline":"Annual meeting elects directors, ratifies auditor; four governance proposals fail to meet 80% supermajority threshold","event_type":"other_material","sec_items":["5.07"],"materiality_score":0.4,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001579684-26-000040","json":"https://secwatch.observer/filing/0001579684-26-000040.json","markdown":"https://secwatch.observer/filing/0001579684-26-000040.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579684/000157968426000040/0001579684-26-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579684/000157968426000040/tday-20260601.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1579684/000157968426000040/0001579684-26-000040-index.htm"}},{"accession":"0001437749-26-019044","ticker":"NSTS","company_name":"NSTS Bancorp, Inc.","filed_at":"2026-06-01T20:16:05+00:00","headline":"NSTS Bancorp annual meeting: directors elected, auditor ratified","event_type":"other_material","sec_items":["5.07"],"materiality_score":0.1,"calibrated_materiality_score":0.1,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-019044","json":"https://secwatch.observer/filing/0001437749-26-019044.json","markdown":"https://secwatch.observer/filing/0001437749-26-019044.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1881592/000143774926019044/0001437749-26-019044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1881592/000143774926019044/nsts20260527_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"nual meeting of shareholders to be held in 2025: For Against Abstain Non-Votes Sangeeta Bhatia 221,206,626 808,512 182,981 11,540,149 Lloyd Carney 213,533,037 8,478,558 186,524 11,540,149 Alan Garber 220,695,587 1,315,689 186,843 11,540,149 Reshma Kewalramani 221,328,875 695,546 173,698 11,540,149 Michel Lagarde 221,776,280 234,937 186,902 11,540,149 Jeffrey Leiden 217,823,643 4,195,522 178,954 11,540,149 Diana McKenzie 218,220,365 3,797,695 180,059 11,540,149 Bruce Sachs 207,616,033 14,397,759 184,327 11,540,149 Jennifer Schneider 221,774,054 240,910 183,155 11,540,149 Nancy Thornberry 221,772,658 241,378 184,083 11,540,149 Suketu Upadhyay 221,237,300 770,815 190,004 11,540,149 Proposal No.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/0000875320-24-000142-index.htm","comparable_excerpt":"PROPOSAL 1: Election of Directors. The election of three (3) director nominees to each serve for a term of three years expiring at the Company’s 2029 Annual Meeting, or until their successors are duly elected and qualified: NAME OF DIRECTOR NOMINEE FOR WITHHELD BROKER NON-VOTES Apolonio Arenas 2,529,046 264,599 1,207,967 Thomas J. Kneesel 2,575,890 217,755 1,207,967 Rodney J. True 2,492,657 300,988 1,207,967","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1881592/000143774926019044/0001437749-26-019044-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}